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Kashmir populationAbstract Background: Primary amenorrhea (PA) is proposed to have multiple etiological factors
that include genetic factors, intrauterine malformations, endocrine dysfunction and environmental
factors, as revealed by previous studies pertaining to amenorrhea. However, among the various pro-
posed etiologies, genetic factors appear to be highly associated with PA as approximately 40% of
PA cases have been found to have genetic causes.
Aim of the study: The present study was proposed to establish the frequency and pattern of
chromosomal abnormalities in PA cases of Kashmir.
Subjects and methods: A total of 108 females within the age group of 14–33 years and having a
history of amenorrhea were included in the study. Peripheral blood lymphocyte cultures were set for
each subject according to standard protocol and chromosomal analysis was carried out on well
spread metaphases by the help of Cytovision software Version 3.9.
Results: The results of the present study reveal that the incidence of chromosomal abnormalities
in PA cases of this region is almost similar with those of many reports around the world. However,
we report two unique chromosomal alterations viz., 46,XX, dup2q(13) and 46,XX, t(2,5)(p11.2;q34)
that have not been found elsewhere in the literature.
Conclusion: The results of the present study indicate that chromosomal analysis of females with
PA, after the exclusion of non-genetic causes, should be essentially considered for the precise diag-
nosis and the development of more successful treatment. The study being the first of its kind in this
part of the world forms the basis for further studies of the PA cases of this region. The precise
molecular characterization of the unique breakpoint regions reported in our study can possibly help
in the identification of new genes involved in primary amenorrhea.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Primary amenorrhea (PA) is the absence of a menstrual period
in a woman of reproductive age. Besides, it is defined as an
absence of secondary sexual characteristics in a female who
has attained an age of 14 but has not attained menarche or
has normal secondary sexual characteristics but has not
26 T.M. Malla et al.attained menarche by 16 years of age [1]. Amenorrhea is a
symptom with many potential causes. PA may be caused by
developmental problems such as the congenital absence of
the uterus and failure of the ovary to receive or maintain egg
cells. The main causes of PA include chromosomal or genetic
abnormalities that can cause the ovaries to stop functioning
normally, hypothalamic or pituitary problems in the brain
and physical problems such as problems with reproductive
organs that can prevent periods from starting and extreme
physical or psychological stress, or a combination of these fac-
tors that can delay the onset of menstruation [2].
According to World Health Organization estimates, amen-
orrhea stands as sixth largest major cause of female infertility.
Additionally, among general population amenorrhea affects
2–5% of all women in the child bearing age [3]. PA is primarily
caused by pituitary/hypothalamic disorders (27.8%); gonadal
dysfunction (50.4%) and outflow tract abnormalities (21.8%)
[4]. However, the diagnosis disparity of amenorrhea is wide
and can vary from endocrine disorders, genetic abnormalities,
psychological, environmental, and structural anomalies. It has
been reported that the percentage of chromosomal abnormal-
ities varies from 15.9% to 63.3% in patients with primary
amenorrhea [5,6]. Several cytogenetic studies have been under-
taken to establish the frequency and type of chromosomal
abnormalities in primary amenorrhea [7,8]. However, no study
has been carried out in the primary amenorrhea cases of
Kashmir, the Northern-most region of India. The present
study was therefore, carried out with a purpose to unveil the
type of chromosomal abnormalities and their frequency in
108 females with PA who were referred to our Center for cyto-
genetic evaluation.
2. Subjects and methods
2.1. Sample collection
The study subjects included patients with PA referred
(n = 108) for chromosomal analysis to the Cytogenetic
Laboratory of Advanced Center for Human Genetics,
SKIMS, Srinagar-India from January 2013 to January 2015.
The study was carried out in accordance with The Code of
Ethics of the World Medical Association (Declaration of
Helsinki) for experiments in humans. An informed consent
was taken from each patient as per the norms of
Institutional Ethics Committee before sample collection. The
age group of the subjects ranged from 14 to 33 years with a
mean of 21.7 ± 5.1 years. Pedigrees with details were drawn
and in depth clinical evaluation and clinical information were
obtained from all subjects. About 1–2 ml of heparinised
peripheral venous blood sample was collected from each
patient aseptically and each sample was given a unique labora-
tory number.
2.2. Setting up of lymphocyte cultures
Lymphocyte cultures were set according to Moorhead et al. [9].
Peripheral venous blood samples were aseptically transferred
into sterile culture tubes with 5–8 ml of RPMI-1640
medium each (Sigma, Michigan, USA), supplemented with
L-glutamine, 10% fetal bovine serum (Himedia Labs, India),
Penicillin–streptomycin solution (Invitrogen, California,USA) and phytohaemagglutinin (Himedia Labs, Mumbai,
India). Parallel cultures were set for each sample. The culture
tubes were marked accordingly and incubated in a CO2 incuba-
tor for 72 h. 50 ll colchicine was added to each culture tube at
the completion of 70 h to arrest the cells at metaphase. After
72 h of incubation, the cell suspensions were centrifuged for
10 min at 1000 rpm. The supernatant was discarded and the pel-
let was treated with hypotonic solution (0.075 MKCl) by gentle
flushing and cyclomixed. The centrifuge tubes were incubated
again at 37 C for 45 min. The tubeswere again centrifuged care-
fully at 1000 rpm for 15 min. The supernatant was removed and
5–8 ml of freshly prepared pre-chilled Cornoys fixative was
added to the pellet while mixing on cyclomixer. The tubes were
allowed to stand overnight and washed with freshly prepared
pre-chilled Cornoys fixative repeatedly for 3–4 times.
2.3. Slide preparation and karyotyping
The slides were prepared by air-drop method and GTG band-
ing was performed. The slides were stained with 1% Giemsa
stain [10]. Karyotyping was performed with the help of
Cytovision software Version 3.9 (Applied Imaging,
Michigan, USA) on well spread G-banded metaphase plates.
At least 30 metaphases were examined for each subject to rule
out any chromosomal anomaly and mosaicism. Karyotypic
reports were based on the International System for Human
Cytogenetic Nomenclature recommendations, 2009.3. Results
A total of 108 females with PA were evaluated for chromoso-
mal abnormalities. Of the total number of females with amen-
orrhea, 70 (64.81%) had a normal karyotype (46,XX) while 38
(35.18%) had abnormal karyotype. The chromosomal abnor-
malities included both numerical as well as structural abnor-
malities. The numerical abnormalities observed in the
patients were monosomy X (45,XO) (Fig. 1), mosaic mono-
somy X (46 XX/45 XO) and sex reversal (46,XY). Structural
abnormalities observed include isochromosome (46,XX,iXq)
(Fig. 2), deletion (46,XX,delXq23-qter) (Fig. 3), duplication
(46 XX, dup2q31) (Fig. 4) and translocation
46,XX/46,XX,t(2;5)(p11.2;q34) (Fig. 5). The detailed kary-
otype particulars of the females, frequencies of different cyto-
genetic alterations, abdominopelvic ultrasonography findings
and the hormonal profiles of the subjects are summarized in
Table 1.4. Discussion
Amenorrhea stands as one of the major causes of female infer-
tility affecting 2–5% of all women of child bearing age [3].
Various conditions like intrauterine malformations, endocrine
dysfunction and genetic factors form the etiological basis of
PA. As revealed by previous studies pertaining to amenorrhea,
approximately 40% of PA cases have been found to have
genetic causes [11]. These can be single gene disorders or chro-
mosomal disorders. However, chromosomal abnormalities
contribute to the constitutional etiology of amenorrhea [12].
Several studies have been carried out to determine the fre-
quency of chromosomal abnormalities among patients with
Figure 1 Representative karyotype (46,XO) of a primary amenorrhea female with Turner’s syndrome.
Figure 2 Representative karyotype (46,XX,i(Xq)) of a primary amenorrhea female with isochromosome Xq.
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of Andhra Pradesh, India (n = 944), Jyothy et al. identified
21.5% of women with PA to have an abnormal karyotype
[17]. However, the literature suggests that no study on cytoge-
netic analysis of PA cases has been carried out in Kashmir
population (North India) and ours is the first report on chro-
mosomal abnormalities in PA females of this region.Among the PA cases referred to our Center, 35.18% had
one or the other chromosomal abnormality. However, evi-
dence suggests that chromosomal abnormalities are present
in 46–62% of patients with primary amenorrhea and the
abnormalities include X chromosome aneuploidy, XY kary-
otype, isochromosome X, isodicentrics, rings, and deleted or
inverted X chromosomes [18]. In an earlier study abnormal
Figure 3 Representative karyotype [46,XX,del(Xq23-qter)] of a primary amenorrhea female with deletion Xq.
Figure 4 Representative karyotype [46,XX,dup(2q31)] of a primary amenorrhea female with duplication 2q.
28 T.M. Malla et al.chromosomal component was reported to be 25.6% in Indian
population [19] and 24.5% in Chinese population [4] among
PA patients. The variation in the frequency of chromosomal
abnormalities in these studies can be attributed to the differ-
ence in the number of subjects and their selection criteria.The abnormalities observed in the subjects of our study
were complete monosomy X (Turner’s syndrome), mosaic
monosomy X (Mosaic Turner’s syndrome), isochromosome
Xq (Variant Turners syndrome), 46,XY (male karyotype),
deletion (Xq) and duplication (2q). Turner’s syndrome








Hormonal status Ultrasonography findings (No.)
Normal
karyotype
46,XX 70 64.81 Increased FSH/LH Normal (22), Mullerain agenesis (12), Hypoplastic
uterus (8), Streak ovaries (17), pre-pubertal uterus
(11)
Numerical abnormality
Monosomy X 45,XO 26 24.07 Increased FSH/LH,
Decreased estradiol
Small atrophied uterus (8), Streak gonads (11),
Absent ovaries (7)
Sex reversal 46,XY 3 2.77 Increased FSH (2),
Increased Testo (1)
Streak gonads (1), rudimentary/absent uterus (1),
Inguinal hernia (1)
Turners mosaic 45,XO/46,XX 5 4.62 Increased FSH/LH Hypoplastic uterus (3), Small ovaries (2)
Structural abnormality
Isochromosome 46,XX,i(Xq) 1 0.92 Increased FSH Streak ovaries, Infantile uterus
Duplication 46,XX,dup(2q31) 1 0.92 Increased FSH/LH Normal findings
Deletion 46,XX,del(Xq23-qter) 1 0.92 Increased FSH Hypoplastic uterus, ovaries not visualized
Translocation 46,XX/
46,XX,t(2;5)(p11.2;q34)
1 0.92 Increased FSH/LH Streak like ovaries, infantile uterus
Figure 5 Representative karyotype [46,XX/46,XX,t(2;5)(p11.2;q34)] of a primary amenorrhea female with translocation (2;5)
chromosomes.
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ing cause of primary amenorrhea as per the published reports
[13] and our results are in good correlation with them as
28.69% of the subjects of our study proved to be Turner
syndromes.
A significant percentage (2.77%) of patients with primary
amenorrhea presented with a male karyotype. This could be
due to the conditions like sex reversal or androgen insensitiv-
ity. All these females appeared tall for their age. Among these,two patients presented to a gynecologist when they were over
the age of 30 years and were married. This emphasizes the
importance of an early cytogenetic diagnosis of these females
so that they could be managed at a proper time.
Deletions involving the long arm of X chromosome
generally results in ovarian failure if they involve the proposed
critical region Xq13-q26 [20]. This explains the cause of one of
our patients with deletion of Xq (Xq23-qter) who had primary
amenorrhea, but no features of Turner’s syndrome.
30 T.M. Malla et al.One of the females was found to have 46,X,i(Xq) karyotype.
She had all features of Turner syndrome. Structural abnormal-
ities leading to PAmostly are isochromosome of the long arm of
X [i(Xq)] [21]. The isochromosome (Xq) appears as a metacen-
tric chromosome that has isologous arms, which are structurally
identical and contain the same genes. This leads to the partial
monosomy of the genes present on Xp and partial trisomy of
genes present on Xq. Females with 46,X,i(Xq) karyotype have
been found to manifest streak gonads. Complete ovarian failure
and partial ovarian failure have also been reported in 91% and
9%of cases with i(Xq) individuals. Besides, short stature andTS
stigmata are found to be frequent with almost complete lack of
gonadal development in 46,X,i(Xq) females. In contrast to this,
50%of females with 46,XX,del (Xp11) karyotypemenstruate or
develop breasts [22].
Duplication of chromosome was observed in one of the
females with a karyotype 46,XX,dup(2q31). In general, dupli-
cations are less harmful than deletions but they inevitably are
associated with some clinical abnormalities. The degree of clin-
ical severity is correlated with the size of the duplicated
segment. Duplication results in partial trisomy of the
chromosomal segment that is duplicated and trisomy of the
genes present in that particular segment. In primary amenor-
rhea cases Xp/q chromosome duplications have been reported
by many studies [3,23]. However, evidence suggests that dupli-
cation 2q31 has not been reported so far in primary amenor-
rhea cases making it a unique one.
Translocation (2;5)(p11.2;q34) is another unique chromo-
somal alteration observed in one of the subjects of our study.
The female was found to be mosaic with karyotype 46,X
X/46,XX,t(2;5)(p11.2;q34). Ultrasonography report of the
patient revealed infantile uterus with bilateral streak ovaries.
While many of them have reported X-autosome translocations
[13,4,24] in PA cases, several other studies at isolated places
have reported autosome-autosome translocations [3,25].
Besides, Tupler et al. have reported two unrelated women with
gonadal dysgenesis who were found to have balanced autoso-
mal translocations i.e. t(6;15)(p21.3;q15) and t(8;9)(p11.2;q12),
respectively [26]. The enigma of gonadal dysgenesis in such
cases could possibly be attributed to the presence of autosomal
gene(s) playing a role in the normal gonadal development [27].5. Conclusion
A significant percentage of the cases of the present study was
found to have chromosomal abnormalities as a plausible cause
of PA. This indicates that chromosomal analysis of females
with PA, after the exclusion of non-genetic causes, should be
essentially considered for the precise diagnosis and develop-
ment of more successful treatment. Moreover, ascertainment
of the karyotyping aids in genotype correlation to understand
clinical heterogeneity, and in genetic counseling. Among the
novel karyotypes, we report for the first time two unique cases
of chromosomal alterations associated with PA. Besides, pre-
cise molecular characterization of these chromosomal alter-
ations could help in identification of new genes or genes
involved in PA and also help in better understanding of molec-
ular mechanism underlying the aberrations. The study being
the first of its kind in this part of the world forms the basis
for further studies of PA patients of this region.Acknowledgment
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